Browse > Article
http://dx.doi.org/10.15616/BSL.2022.28.2.59

Emerging Mechanisms of Cyr61/CTGF/NOV Secretion in the Nervous System  

Yang, Hayoung (Department of Biochemistry, Chungbuk National University)
Park, Young-Jun (Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology)
Shim, Sungbo (Department of Biochemistry, Chungbuk National University)
Publication Information
Biomedical Science Letters / v.28, no.2, 2022 , pp. 59-66 More about this Journal
Abstract
The Cyr61/CTGF/NOV (CCN) family is dynamically expressed in various tissues, including the nervous system, from the prenatal period to adulthood. However, major studies have been conducted only in limited fields, such as the cardiovascular and muscular systems, skeletal development, and cancer. In addition, although the CCN family is a secretory protein, very few studies have described its mechanism of secretion. Recently, it has been suggested that overexpression of CCN3 or intracellular accumulation due to problems in the secretory pathway can inhibit neuronal axonal growth. In this review, we have briefly summarized the structure and characteristics of the CCN family and its related diseases, with particular emphasis on the secretory mechanism and modifiers of the CCN family, newly identified in the nervous system.
Keywords
CCN family; Nervous system; Secretory protein; Post-translational modifications; Palmitoylation; zDHHC palmitoyl acyltransferase;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Mason HR, Lake AC, Wubben JE, Nowak RA, Castellot JJ, Jr. The growth arrest-specific gene CCN5 is deficient in human leiomyomas and inhibits the proliferation and motility of cultured human uterine smooth muscle cells. Mol Hum Reprod. 2004. 10: 181-187.   DOI
2 Mo FE, Muntean AG, Chen CC, Stolz DB, Watkins SC, Lau LF. CYR61 (CCN1) is essential for placental development and vascular integrity. Mol Cell Biol. 2002. 22: 8709-8720.   DOI
3 Niwa Y, Suzuki T, Dohmae N, Simizu S. O-Fucosylation of CCN1 is required for its secretion. FEBS Lett. 2015. 589: 3287-3293.   DOI
4 Perrot A, Schmitt KR, Roth EM, Stiller B, Posch MG, Browne EN, et al. CCN1 mutation is associated with atrial septal defect. Pediatr Cardiol. 2015. 36: 295-299.   DOI
5 Resh MD. Trafficking and signaling by fatty-acylated and prenylated proteins. Nature Chemical Biology. 2006. 2: 584-590.   DOI
6 Resh MD. Palmitoylation of Hedgehog proteins by Hedgehog acyltransferase: roles in signalling and disease. Open Biol. 2021. 11: 200414.   DOI
7 Saleem AN, Chen YH, Baek HJ, Hsiao YW, Huang HW, Kao HJ, et al. Mice with alopecia, osteoporosis, and systemic amyloidosis due to mutation in Zdhhc13, a gene coding for palmitoyl acyltransferase. PLoS Genet. 2010. 6: e1000985.   DOI
8 Singaraja RR, Huang K, Sanders SS, Milnerwood AJ, Hines R, Lerch JP, et al. Altered palmitoylation and neuropathological deficits in mice lacking HIP14. Human Molecular Genetics. 2011. 20: 3899-3909.   DOI
9 Tanaka S, Sugimachi K, Saeki H, Kinoshita J, Ohga T, Shimada M, et al. A novel variant of WISP1 lacking a Von Willebrand type C module overexpressed in scirrhous gastric carcinoma. Oncogene. 2001. 20: 5525-5532.   DOI
10 Wang S, Chong ZZ, Shang YC, Maiese K. Wnt1 inducible signaling pathway protein 1 (WISP1) blocks neurodegeneration through phosphoinositide 3 kinase/Akt1 and apoptotic mitochondrial signaling involving Bad, Bax, Bim, and Bcl-xL. Curr Neurovasc Res. 2012. 9: 20-31.   DOI
11 Yu Y, Hu M, Xing X, Li F, Song Y, Luo Y, et al. Identification of a mutation in the WISP3 gene in three unrelated families with progressive pseudorheumatoid dysplasia. Mol Med Rep. 2015. 12: 419-425.   DOI
12 Komekado H, Yamamoto H, Chiba T, Kikuchi A. Glycosylation and palmitoylation of Wnt-3a are coupled to produce an active form of Wnt-3a. Genes Cells. 2007. 12: 521-534.   DOI
13 Katoh M, Katoh M. Comparative genomics on Norrie disease gene. International Journal of Molecular Medicine. 2005. 15: 885-889.
14 Baguma-Nibasheka M, Kablar B. Pulmonary hypoplasia in the connective tissue growth factor (Ctgf) null mouse. Dev Dyn. 2008. 237: 485-493.   DOI
15 Baker N, Sharpe P, Culley K, Otero M, Bevan D, Newham P, et al. Dual regulation of metalloproteinase expression in chondrocytes by Wnt-1-inducible signaling pathway protein 3/CCN6. Arthritis Rheum. 2012. 64: 2289-2299.   DOI
16 Bohr W, Kupper M, Hoffmann K, Weiskirchen R. Recombinant expression, purification, and functional characterisation of connective tissue growth factor and nephroblastoma-overexpressed protein. PLoS One. 2010. 5: e16000.   DOI
17 Brigstock DR. The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr Rev. 1999. 20: 189-206.   DOI
18 Chamberlain LH, Shipston MJ. The physiology of protein Sacylation. Physiol Rev. 2015. 95: 341-376.   DOI
19 Chamoun Z, Mann RK, Nellen D, von Kessler DP, Bellotto M, Beachy PA, et al. Skinny hedgehog, an acyltransferase required for palmitoylation and activity of the hedgehog signal. Science. 2001. 293: 2080-2084.   DOI
20 Chen CC, Lau LF. Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol. 2009. 41: 771-783.   DOI
21 Gao X, Hannoush RN. Single-cell imaging of Wnt palmitoylation by the acyltransferase porcupine. Nat Chem Biol. 2014. 10: 61-68.   DOI
22 Hall-Glenn F, De Young RA, Huang BL, van Handel B, Hofmann JJ, Chen TT, et al. CCN2/connective tissue growth factor is essential for pericyte adhesion and endothelial basement membrane formation during angiogenesis. PLoS One. 2012. 7: e30562.   DOI
23 Heath E, Tahri D, Andermarcher E, Schofield P, Fleming S, Boulter CA. Abnormal skeletal and cardiac development, cardiomyopathy, muscle atrophy and cataracts in mice with a targeted disruption of the Nov (Ccn3) gene. BMC Dev Biol. 2008. 8: 18.   DOI
24 Holbourn KP, Acharya KR, Perbal B. The CCN family of proteins: structure-function relationships. Trends Biochem Sci. 2008. 33: 461-473.   DOI
25 Ishizawa Y, Niwa Y, Suzuki T, Kawahara R, Dohmae N, Simizu S. Identification and characterization of collagen-like glycosylation and hydroxylation of CCN1. Glycobiology. 2019. 29: 696-704.   DOI
26 Ivkovic S, Yoon BS, Popoff SN, Safadi FF, Libuda DE, Stephenson RC, et al. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development. 2003. 130: 2779-2791.   DOI
27 Jones JA, Gray MR, Oliveira BE, Koch M, Castellot JJ, Jr. CCN5 expression in mammals: I. Embryonic and fetal tissues of mouse and human. J Cell Commun Signal. 2007. 1: 127-143.   DOI
28 Gray MR, Malmquist JA, Sullivan M, Blea M, Castellot JJ, Jr. CCN5 Expression in mammals. II. Adult rodent tissues. J Cell Commun Signal. 2007. 1: 145-158.   DOI
29 Jun JI, Lau LF. Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets. Nat Rev Drug Discov. 2011. 10: 945-963.   DOI
30 Kim H, Son S, Shin I. Role of the CCN protein family in cancer. BMB Reports. 2018a. 51: 486.   DOI
31 Kim Y, Yang H, Min JK, Park YJ, Jeong SH, Jang SW, et al. CCN3 secretion is regulated by palmitoylation via ZDHHC22. Biochem Biophys Res Commun. 2018b. 495: 2573-2578.   DOI
32 Kireeva ML, Latinkic BV, Kolesnikova TV, Chen CC, Yang GP, Abler AS, et al. Cyr61 and Fisp12 are both ECM-associated signaling molecules: activities, metabolism, and localization during development. Exp Cell Res. 1997. 233: 63-77.   DOI
33 Krupska I, Bruford EA, Chaqour B. Eyeing the Cyr61/CTGF/NOV (CCN) group of genes in development and diseases: highlights of their structural likenesses and functional dissimilarities. Human Genomics. 2015. 9: 1-13.   DOI
34 French DM, Kaul RJ, D'souza AL, Crowley CW, Bao M, Frantz GD, et al. WISP-1 is an osteoblastic regulator expressed during skeletal development and fracture repair. The American Journal of Pathology. 2004. 165: 855-867.   DOI
35 Lake AC, Castellot JJ. CCN5 modulates the antiproliferative effect of heparin and regulates cell motility in vascular smooth muscle cells. Cell Communication and Signaling. 2003. 1: 1-13.   DOI
36 Latinkic BV, Mo FE, Greenspan JA, Copeland NG, Gilbert DJ, Jenkins NA, et al. Promoter function of the angiogenic inducer Cyr61gene in transgenic mice: tissue specificity, inducibility during wound healing, and role of the serum response element. Endocrinology. 2001. 142: 2549-2557.   DOI
37 Leask A, Abraham DJ. All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci. 2006. 119: 4803-4810.   DOI
38 Li Y, Hu J, Hofer K, Wong AM, Cooper JD, Birnbaum SG, et al. DHHC5 interacts with PDZ domain 3 of post-synaptic density95 (PSD-95) protein and plays a role in learning and memory. J Biol Chem. 2010. 285: 13022-13031.   DOI
39 Mikels AJ, Nusse R. Wnts as ligands: processing, secretion and reception. Oncogene. 2006. 25: 7461-7468.   DOI
40 Greaves J, Chamberlain LH. DHHC palmitoyl transferases: substrate interactions and (patho)physiology. Trends Biochem Sci. 2011. 36: 245-253.   DOI
41 Hall-Glenn F, Aivazi A, Akopyan L, Ong JR, Baxter RR, Benya PD, et al. CCN2/CTGF is required for matrix organization and to protect growth plate chondrocytes from cellular stress. J Cell Commun Signal. 2013. 7: 219-230.   DOI
42 Leask A, Parapuram SK, Shi-Wen X, Abraham DJ. Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease? J Cell Commun Signal. 2009. 3: 89-94.   DOI
43 Su BY, Cai WQ, Zhang CG, Martinez V, Lombet A, Perbal B. The expression of ccn3 (nov) RNA and protein in the rat central nervous system is developmentally regulated. Mol Pathol. 2001. 54: 184-191.   DOI
44 Lafont J, Thibout H, Dubois C, Laurent M, Martinerie C. NOV/CCN3 induces adhesion of muscle skeletal cells and cooperates with FGF2 and IGF-1 to promote proliferation and survival. Cell Communication & Adhesion. 2005. 12: 41-57.   DOI
45 Mo FE, Lau LF. The matricellular protein CCN1 is essential for cardiac development. Circ Res. 2006. 99: 961-969.   DOI
46 Mukai J, Dhilla A, Drew LJ, Stark KL, Cao L, MacDermott AB, et al. Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion. Nat Neurosci. 2008. 11: 1302-1310.   DOI
47 Partridge EA, Hanna BD, Panitch HB, Rintoul NE, Peranteau WH, Flake AW, et al. Pulmonary hypertension in giant omphalocele infants. J Pediatr Surg. 2014. 49: 1767-1770.   DOI
48 Perbal B. "Knock once for yes, twice for no". J Cell Commun Signal. 2015. 9: 15-18.   DOI
49 Putilina T, Wong P, Gentleman S. The DHHC domain: a new highly conserved cysteine-rich motif. Mol Cell Biochem. 1999. 195: 219-226.   DOI
50 Ray G, Banerjee S, Saxena NK, Campbell DR, Van Veldhuizen P, Banerjee SK. Stimulation of MCF-7 tumor progression in athymic nude mice by 17beta-estradiol induces WISP-2/CCN5 expression in xenografts: a novel signaling molecule in hormonal carcinogenesis. Oncol Rep. 2005. 13: 445-448.
51 Ueberham U, Ueberham E, Gruschka H, Arendt T. Connective tissue growth factor in Alzheimer's disease. Neuroscience. 2003. 116: 1-6.   DOI
52 Vasudevan D, Haltiwanger RS. Novel roles for O-linked glycans in protein folding. Glycoconj J. 2014. 31: 417-426.   DOI
53 Xu J, Smock SL, Safadi FF, Rosenzweig AB, Odgren PR, Marks SC, Jr., et al. Cloning the full-length cDNA for rat connective tissue growth factor: implications for skeletal development. J Cell Biochem. 2000. 77: 103-115.
54 Yang W, Wagener J, Wolf N, Schmidt M, Kimmig R, Winterhager E, et al. Impact of CCN3 (NOV) glycosylation on migration/invasion properties and cell growth of the choriocarcinoma cell line Jeg3. Hum Reprod. 2011. 26: 2850-2860.   DOI
55 Zhao Z, Ho L, Wang J, Qin W, Festa ED, Mobbs C, et al. Connective tissue growth factor (CTGF) expression in the brain is a downstream effector of insulin resistance-associated promotion of Alzheimer's disease beta-amyloid neuropathology. Faseb J. 2005. 19: 2081-2082.   DOI
56 Globa AK, Bamji SX. Protein palmitoylation in the development and plasticity of neuronal connections. Curr Opin Neurobiol. 2017. 45: 210-220.   DOI
57 Myers RB, Rwayitare K, Richey L, Lem J, Castellot JJ. CCN5 Expression in mammals. III. Early embryonic mouse development. Journal of Cell Communication and Signaling. 2012. 6: 217-223.   DOI
58 Shimoyama T, Hiraoka SI, Takemoto M, Koshizaka M, Tokuyama H, Tokuyama T, et al. CCN3 inhibits neointimal hyperplasia through modulation of smooth muscle cell growth and migration. Arteriosclerosis, Thrombosis, and Vascular Biology. 2010. 30: 675-682.   DOI